We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+7.46%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$29.6B
AUM Growth
+$2.54B
Cap. Flow
+$740M
Cap. Flow %
2.5%
Top 10 Hldgs %
36.41%
Holding
1,385
New
83
Increased
652
Reduced
368
Closed
52

Top Buys

Rank Stock Value
1
CRWD icon
CrowdStrike
CRWD
+$163M
2
NOW icon
ServiceNow
NOW
+$139M
3
ELS icon
Equity Lifestyle Properties
ELS
+$137M
4
CCI icon
Crown Castle
CCI
+$118M
5
NFLX icon
Netflix
NFLX
+$115M

Sector Composition

Rank Sector Weight
1 Technology 30%
2 Real Estate 28.67%
3 Communication Services 10.86%
4 Consumer Discretionary 6.91%
5 Financials 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EWTX icon
1176
Edgewise Therapeutics
EWTX
$4.29B
$6K ﹤0.01%
344
GPCR icon
1177
Structure Therapeutics
GPCR
$3.39B
$6K ﹤0.01%
226
MNKD icon
1178
MannKind Corp
MNKD
$1.2B
$6K ﹤0.01%
1,058
SRPT icon
1179
Sarepta Therapeutics
SRPT
$1.61B
$6K ﹤0.01%
315
-35,000
-99% -$624K
TVTX icon
1180
Travere Therapeutics
TVTX
$5.12B
$6K ﹤0.01%
258
TWST icon
1181
Twist Bioscience
TWST
$5.3B
$6K ﹤0.01%
210
VGLT icon
1182
Vanguard Long-Term Treasury ETF
VGLT
$10.2B
$6K ﹤0.01%
+108
New +$6.02K
XLI icon
1183
State Street Industrial Select Sector SPDR ETF
XLI
$32.5B
$6K ﹤0.01%
38
AUPH icon
1184
Aurinia Pharmaceuticals
AUPH
$1.92B
$5K ﹤0.01%
413
-115
-22% -$1.26K
AVDL
1185
DELISTED
Avadel Pharmaceuticals
AVDL
$5K ﹤0.01%
332
BCRX icon
1186
BioCryst Pharmaceuticals
BCRX
$2.43B
$5K ﹤0.01%
692
DBC icon
1187
Invesco DB Commodity Index Tracking Fund
DBC
$1.69B
$5K ﹤0.01%
200
DYN icon
1188
Dyne Therapeutics
DYN
$4.25B
$5K ﹤0.01%
371
GMAB icon
1189
Genmab
GMAB
$17.5B
$5K ﹤0.01%
159
HRMY icon
1190
Harmony Biosciences
HRMY
$2.07B
$5K ﹤0.01%
189
HROW icon
1191
Harrow
HROW
$1.44B
$5K ﹤0.01%
110
IMCR icon
1192
Immunocore
IMCR
$1.68B
$5K ﹤0.01%
138
JANX icon
1193
Janux Therapeutics
JANX
$893M
$5K ﹤0.01%
187
KNSA icon
1194
Kiniksa Pharmaceuticals
KNSA
$6.13B
$5K ﹤0.01%
139
NVCR icon
1195
NovoCure
NVCR
$1.8B
$5K ﹤0.01%
357
SNDX icon
1196
Syndax Pharmaceuticals
SNDX
$1.69B
$5K ﹤0.01%
314
TRML
1197
DELISTED
Tourmaline Bio
TRML
$5K ﹤0.01%
95
VCEL icon
1198
Vericel Corp
VCEL
$2.34B
$5K ﹤0.01%
163
VERA icon
1199
Vera Therapeutics
VERA
$2.31B
$5K ﹤0.01%
182
XLC icon
1200
State Street Communication Services Select Sector SPDR ETF
XLC
$22.5B
$5K ﹤0.01%
44
+2
+5% +$222

Similar funds

Daiwa Securities Group's Q3 2025 Portfolio in Review

As of Q3 2025, Daiwa Securities Group held 1,385 positions worth $29.6B, up 9.4% from $27.1B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Daiwa Securities Group's Q3 2025 filing shows 83 new, 652 increased, 368 reduced and 52 closed positions. Its largest new stake was Eagle Materials: 54,795 shares worth $12.8M. The largest sale was Global X Conscious Companies ETF, an estimated $130M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Real Estate and Communication Services.

  • Daiwa Securities Group's largest Q3 2025 buy was Eagle Materials: 54,795 shares worth $12.8M.
  • Daiwa Securities Group added most to CrowdStrike in Q3 2025, an estimated $163M increase.
  • Daiwa Securities Group's biggest Q3 2025 reduction was Global X Conscious Companies ETF, cutting an estimated $130M.
  • Daiwa Securities Group fully exited Ansys in Q3 2025, selling an estimated $6.94M.
  • Daiwa Securities Group's ten largest holdings make up 36% of its $29.6B portfolio in Q3 2025.
  • Daiwa Securities Group opened 83 new positions and closed 52 in Q3 2025.
  • Daiwa Securities Group's portfolio value rose 9.4% quarter-over-quarter to $29.6B.

Based on Daiwa Securities Group's 13F filing for Q3 2025, filed 14 Nov 2025.